Investors purchased shares of Humana Inc. (NYSE:HUM) on weakness during trading on Thursday after Royal Bank Of Canada lowered their price target on the stock from $222.00 to $217.00. $297.61 million flowed into the stock on the tick-up and $272.80 million flowed out of the stock on the tick-down, for a money net flow of $24.81 million into the stock. Of all stocks tracked, Humana had the 15th highest net in-flow for the day. Humana traded down ($9.09) for the day and closed at $168.44
A number of other analysts also recently issued reports on HUM. Cantor Fitzgerald reissued a “buy” rating on shares of Humana in a research report on Saturday, July 9th. RBC Capital Markets reissued a “buy” rating and set a $224.00 target price (up previously from $220.00) on shares of Humana in a research report on Friday, July 22nd. Jefferies Group dropped their target price on shares of Humana from $220.00 to $217.00 and set a “buy” rating for the company in a research report on Thursday, August 4th. Barclays PLC dropped their target price on shares of Humana from $193.00 to $191.00 and set an “equal weight” rating for the company in a research report on Thursday, August 4th. Finally, Evercore ISI assumed coverage on shares of Humana in a research report on Thursday, September 22nd. They set a “buy” rating and a $200.00 target price for the company. Seven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Humana presently has a consensus rating of “Buy” and a consensus price target of $200.50.
Several large investors have recently bought and sold shares of HUM. Point72 Asia Hong Kong Ltd purchased a new stake in Humana during the second quarter valued at about $126,000. Daiwa SB Investments Ltd. raised its stake in shares of Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock valued at $129,000 after buying an additional 10 shares in the last quarter. Bessemer Group Inc. raised its stake in shares of Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock valued at $183,000 after buying an additional 797 shares in the last quarter. Fulton Bank N.A. bought a new stake in shares of Humana during the third quarter valued at $229,000. Finally, BB&T Securities LLC raised its stake in shares of Humana by 13.6% in the second quarter. BB&T Securities LLC now owns 1,374 shares of the insurance provider’s stock valued at $247,000 after buying an additional 165 shares in the last quarter. 93.24% of the stock is currently owned by institutional investors and hedge funds.
The company has a market cap of $25.46 billion, a PE ratio of 26.24 and a beta of 0.90. The firm has a 50 day moving average of $175.94 and a 200 day moving average of $175.74.
Humana (NYSE:HUM) last released its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.23 by $0.07. The firm had revenue of $14 billion for the quarter, compared to analyst estimates of $13.59 billion. Humana had a return on equity of 11.11% and a net margin of 1.76%. The company’s revenue was up 2.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.67 EPS. On average, equities research analysts anticipate that Humana Inc. will post $9.24 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be issued a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a yield of 0.68%. The ex-dividend date is Tuesday, October 11th. Humana’s dividend payout ratio (DPR) is currently 18.18%.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.